Leading Growth
Strategic Acquisitions:
- 1978 Bayer purchases Miles Laboratories (acquires Alka-Seltzer® and Flintstones® vitamins)
- 1994 Bayer Consumer Care division created after acquisition of Sterling Winthrop
- 1996 Established 50:50 joint venture in the USA with Roche covering analgesics and vaginal yeast infection categories.
- 2005 Bayer acquires Roche Consumer Health (includes Aleve®, Redoxon®, Bepanthen®, Supradyn®, Berocca® and Elevit Pronatal®)
- 2007 Bayer Consumer Care expands marketing and sales capabilities in Eastern Europe with acquisition of Pharmonyx, Ltd.
- 2007 Bayer Consumer Care acquires Citracal® line of OTC calcium supplements from Mission Pharmacal Company
- 2008 Bayer Consumer Care acquires Sagmel, Inc. over-the-counter brand portfolio and related assets including Theraflex®, Calcemin®, Nazol® and Relief® in the fast-growing (Eastern European and Central Asian Region)
- 2008 Bayer Consumer Care acquires over-the-counter Cough & Cold portfolio from Topsun Science & Technology Co., Ltd.
The Opportunities for Growth Continue
Overall sales of our products in emerging markets have been strongly growing over the past years. Today, we are aggressively investing in fast-growing regions around the world to advance our international portfolio of products. Recent investments in China and Eastern Europe and Central Asia are excellent examples of this.
Bayer Consumer Care is a key part of Bayer HealthCare and we will continue to make the necessary investments to maintain a well-balanced portfolio between developed and developing nations offering consumers around the world a range of innovative OTC products that meet their everyday health and wellness needs.
